SNX — Synectics Income Statement
0.000.00%
Last trade - 00:00
- £34.34m
- £31.68m
- £49.13m
- 79
- 58
- 96
- 93
2019 November 30th | 2020 November 30th | R2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68.5 | 44.6 | 36.6 | 39.1 | 49.1 |
Cost of Revenue | |||||
Gross Profit | 23.3 | 14.6 | 14.1 | 16.6 | 20 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 66.9 | 50.8 | 37.1 | 38.6 | 46.4 |
Operating Profit | 1.65 | -6.15 | -0.454 | 0.494 | 2.75 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.55 | -6.29 | -0.558 | 0.361 | 2.65 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.63 | -4.67 | -0.442 | 0.639 | 2.16 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1.63 | -4.67 | -0.479 | 1.47 | 2.16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.63 | -4.67 | -0.479 | 1.47 | 2.16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.161 | -0.192 | -0.049 | 0.081 | 0.15 |
Dividends per Share |